Annual ROE
-75.51%
-35.53%-88.87%
December 31, 2023
Summary
- As of February 7, 2025, GLUE annual return on equity is -75.51%, with the most recent change of -35.53% (-88.87%) on December 31, 2023.
- During the last 3 years, GLUE annual ROE has fallen by -149.14% (-202.55%).
- GLUE annual ROE is now -202.55% below its all-time high of 73.63%, reached on December 31, 2020.
Performance
GLUE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-62.68%
+7.72%+10.97%
September 30, 2024
Summary
- As of February 7, 2025, GLUE quarterly return on equity is -62.68%, with the most recent change of +7.72% (+10.97%) on September 30, 2024.
- Over the past year, GLUE quarterly ROE has increased by +11.45% (+15.45%).
- GLUE quarterly ROE is now -178.14% below its all-time high of 80.21%, reached on March 31, 2021.
Performance
GLUE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
GLUE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.9% | +15.4% |
| 3 y3 years | -202.6% | -71.9% |
| 5 y5 years | -218.5% | -71.9% |
GLUE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -254.8% | at low | -156.2% | +15.4% |
| 5 y | 5-year | -202.6% | at low | -178.1% | +15.4% |
| alltime | all time | -202.6% | at low | -178.1% | +15.4% |
Monte Rosa Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -62.68%(-11.0%) |
| Jun 2024 | - | -70.40%(-5.0%) |
| Mar 2024 | - | -74.13%(+12.4%) |
| Dec 2023 | -75.51%(+88.9%) | -65.93%(+13.3%) |
| Sep 2023 | - | -58.20%(+18.4%) |
| Jun 2023 | - | -49.15%(+16.8%) |
| Mar 2023 | - | -42.09%(+15.4%) |
| Dec 2022 | -39.98% | -36.46%(+14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -31.95%(+14.7%) |
| Jun 2022 | - | -27.86%(+13.9%) |
| Mar 2022 | - | -24.47%(-16.2%) |
| Dec 2021 | -21.28%(-128.9%) | -29.21%(-35.8%) |
| Sep 2021 | - | -45.52%(-34.0%) |
| Jun 2021 | - | -69.01%(-186.0%) |
| Mar 2021 | - | 80.21%(+8.9%) |
| Dec 2020 | 73.63%(+15.6%) | 73.63% |
| Dec 2019 | 63.71% | - |
FAQ
- What is Monte Rosa Therapeutics annual return on equity?
- What is the all time high annual ROE for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual ROE year-on-year change?
- What is Monte Rosa Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly ROE year-on-year change?
What is Monte Rosa Therapeutics annual return on equity?
The current annual ROE of GLUE is -75.51%
What is the all time high annual ROE for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual return on equity is 73.63%
What is Monte Rosa Therapeutics annual ROE year-on-year change?
Over the past year, GLUE annual return on equity has changed by -35.53% (-88.87%)
What is Monte Rosa Therapeutics quarterly return on equity?
The current quarterly ROE of GLUE is -62.68%
What is the all time high quarterly ROE for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly return on equity is 80.21%
What is Monte Rosa Therapeutics quarterly ROE year-on-year change?
Over the past year, GLUE quarterly return on equity has changed by +11.45% (+15.45%)